APWCA Position Statement: Point-of-care bacterial autofluorescence imaging in the assessment and management of hard-to-heal wounds
DOI:
https://doi.org/10.63676/0xfch690Keywords:
Bacterial load, Debridement, Point-of-care systems, Optical imagingReferences
Le L, Baer M, Briggs P, et al. Diagnostic accuracy of point-of-care fluorescence imaging for the detection of bacterial burden in wounds: results from the 350-patient Fluorescence Imaging Assessment and Guidance trial. Adv Wound Care (New Rochelle). 2021;10(3):123-136. https://doi.org/10.1089/wound.2020.1272
Jacob A, Jones LM, Abdo RJ, et al. Lights, fluorescence, action. Influencing wound treatment plans including debridement of bacteria and biofilms. Int Wound J. 2023;20(8):3279-3288. https://doi.org/10.1111/iwj.14208
Trafelet N, Johnson S, Schroder J, Serena TE. Audit of antimicrobial prescribing trends in 1447 outpatient wound assessments: baseline rates and impact of bacterial fluorescence imaging. Diagnostics (Basel). 2024;14(18):2034. https://doi.org/10.3390/diagnostics14182034
Price N. Routine fluorescence imaging to detect wound bacteria reduces antibiotic use and antimicrobial dressing expenditure while improving healing rates: retrospective analysis of 229 foot ulcers. Diagnostics (Basel). 2020;10(11):927. https://doi.org/10.3390/diagnostics10110927
Hsu JC, Chu YH, Wu YC, et al. Application of perioperative real-time fluorescence imaging to achieve high-quality debridement: a randomized control trial. Adv Wound Care (New Rochelle). 2026;15(10):722-734. https://doi.org/10.1177/21621918251359558
Rahma S, Woods J, Brown S, Nixon J, Russell D. The use of point-of-care bacterial autofluorescence imaging in the management of diabetic foot ulcers: a pilot randomized controlled trial. Diabetes Care. 2022;45(7):1601-1609. https://doi.org/10.2337/dc21-2218
Kelso MR, Jaros M. Improving wound healing and infection control in long-term care with bacterial fluorescence imaging. Adv Skin Wound Care. 2024;37(9):471-479. https://doi.org/10.1097/ASW.0000000000000177
Medicare Administrative Contractors. Proposed local coverage determinations: real-time fluorescence wound imaging. CGS DL40468; First Coast Service Options DL40415; Noridian DL40441; Novitas Solutions DL40413; Palmetto GBA DL40443; Wellpoint Federal (National Government Services) DL40439; WPS DL40437. Comment period ends November 14, 2026. Medicare Coverage Database. https://www.cms.gov/medicare-coverage-database (accessed 15 October 2026)
Frykberg RG, Banks J. Challenges in the treatment of chronic wounds. Adv Wound Care (New Rochelle). 2015;4(9):560-582. https://doi.org/10.1089/wound.2015.0635
Li M, Hou Q, Zhong L, Zhao Y, Fu X. Macrophage related chronic inflammation in non-healing wounds. Front Immunol. 2021;12:681710. https://doi.org/10.3389/fimmu.2021.681710
Versey Z, da Cruz Nizer WS, Russell E, et al. Biofilm-innate immune interface: contribution to chronic wound formation. Front Immunol. 2021;12:648554. https://doi.org/10.3389/fimmu.2021.648554
Wolcott RD, Gontcharova V, Sun Y, Dowd SE. Evaluation of the bacterial diversity among and within individual venous leg ulcers using bacterial tag-encoded FLX and titanium amplicon pyrosequencing and metagenomic approaches. BMC Microbiol. 2009;9:226. https://doi.org/10.1186/1471-2180-9-226
Wolcott RD, Hanson JD, Rees EJ, et al. Analysis of the chronic wound microbiota of 2,963 patients by 16S rDNA pyrosequencing. Wound Repair Regen. 2016;24(1):163-174. https://doi.org/10.1111/wrr.12370
Fazli M, Bjarnsholt T, Kirketerp-Møller K, et al. Nonrandom distribution of Pseudomonas aeruginosa and Staphylococcus aureus in chronic wounds. J Clin Microbiol. 2009;47(12):4084-4089. https://doi.org/10.1128/JCM.01395-09
Rhoads DD, Cox SB, Rees EJ, Sun Y, Wolcott RD. Clinical identification of bacteria in human chronic wound infections: culturing vs. 16S ribosomal DNA sequencing. BMC Infect Dis. 2012;12:321. https://doi.org/10.1186/1471-2334-12-321
Reddy M, Gill SS, Wu W, Kalkar SR, Rochon PA. Does this patient have an infection of a chronic wound? JAMA. 2012;307(6):605-611. https://doi.org/10.1001/jama.2012.98
Raizman R, Dunham D, Lindvere-Teene L, et al. Use of a bacterial fluorescence imaging device: wound measurement, bacterial detection and targeted debridement. J Wound Care. 2019;28(12):824-834. https://doi.org/10.12968/jowc.2019.28.12.824
Moelleken M, Jockenhöfer F, Benson S, Dissemond J. Prospective clinical study on the efficacy of bacterial removal with mechanical debridement in and around chronic leg ulcers assessed with fluorescence imaging. Int Wound J. 2020;17(4):1011-1018. https://doi.org/10.1111/iwj.13345
Serena TE, Harrell K, Serena L, Yaakov RA. Real-time bacterial fluorescence imaging accurately identifies wounds with moderate-to-heavy bacterial burden. J Wound Care. 2019;28(6):346-357. https://doi.org/10.12968/jowc.2019.28.6.346
Gurtner GC, Werner S, Barrandon Y, Longaker MT. Wound repair and regeneration. Nature. 2008;453(7193):314-321. https://doi.org/10.1038/nature07039
Eming SA, Martin P, Tomic-Canic M. Wound repair and regeneration: mechanisms, signaling, and translation. Sci Transl Med. 2014;6(265):265sr6. https://doi.org/10.1126/scitranslmed.3009337
Wilkinson HN, Hardman MJ. Wound healing: cellular mechanisms and pathological outcomes. Open Biol. 2020;10(9):200223. https://doi.org/10.1098/rsob.200223
Zhao R, Liang H, Clarke E, Jackson C, Xue M. Inflammation in chronic wounds. Int J Mol Sci. 2016;17(12):2085. https://doi.org/10.3390/ijms17122085
Senneville É, Albalawi Z, van Asten SA, et al. IWGDF/IDSA guidelines on the diagnosis and treatment of diabetes-related foot infections (IWGDF/IDSA 2023). Diabetes Metab Res Rev. 2024;40(3):e3687.https://doi.org/10.1002/dmrr.3687
Armstrong DG, Edmonds ME, Serena TE. Point-of-care fluorescence imaging reveals extent of bacterial load in diabetic foot ulcers. Int Wound J. 2023;20(2):554-566. https://doi.org/10.1111/iwj.14080
Armstrong DG, Armstrong AA, Feraru LM, Deng W. Surgically rebooting the wound for a healthier operating system: why the apps will not run until you reset the wound operating system. Burns Trauma. 2026:tkag053. https://doi.org/10.1093/burnst/tkag053
Rennie MY, Dunham D, Lindvere-Teene L, Raizman R, Hill R, Linden R. Understanding real-time fluorescence signals from bacteria and wound tissues observed with the MolecuLight i:X. Diagnostics (Basel). 2019;9(1):22. https://doi.org/10.3390/diagnostics9010022
Jones LM, Dunham D, Rennie MY, et al. In vitro detection of porphyrin-producing wound bacteria with real-time fluorescence imaging. Future Microbiol. 2020;15:319-332. https://doi.org/10.2217/fmb-2019-0279
US Food and Drug Administration. De Novo classification request DEN180008 (MolecuLight i:X; product code QCR), granted July 31, 2018; and 510(k) premarket notifications under product code QJF, including K213840 indications for use, and the 510(k) summaries for K242669 (SnapshotGLO; March 26, 2025) and K251678 (Swift Ray 1; February 24, 2026). https://www.accessdata.fda.gov (accessed 15 October 2026)
DaCosta RS, Kulbatski I, Lindvere-Teene L, et al. Point-of-care autofluorescence imaging for real-time sampling and treatment guidance of bioburden in chronic wounds: first-in-human results. PLoS One. 2015;10(3):e0116623. https://doi.org/10.1371/journal.pone.0116623
Rennie MY, Lindvere-Teene L, Tapang K, Linden R. Point-of-care fluorescence imaging predicts the presence of pathogenic bacteria in wounds: a clinical study. J Wound Care. 2017;26(8):452-460. https://doi.org/10.12968/jowc.2017.26.8.452
Sandy-Hodgetts K, Andersen CA, Al-Jalodi O, Serena L, Teimouri C, Serena TE. Uncovering the high prevalence of bacterial burden in surgical site wounds with point-of-care fluorescence imaging. Int Wound J. 2022;19(6):1438-1448. https://doi.org/10.1111/iwj.13737
Johnson J, Johnson AR Jr, Andersen CA, Kelso MR, Oropallo AR, Serena TE. Skin pigmentation impacts the clinical diagnosis of wound infection: imaging of bacterial burden to overcome diagnostic limitations. J Racial Ethn Health Disparities. 2024;11(2):1045-1055. https://doi.org/10.1007/s40615-023-01584-8
Hurley CM, McClusky P, Sugrue RM, Clover JA, Kelly JE. Efficacy of a bacterial fluorescence imaging device in an outpatient wound care clinic: a pilot study. J Wound Care. 2019;28(7):438-443. https://doi.org/10.12968/jowc.2019.28.7.438
Blackshaw EL, Jeffery SLA. Efficacy of an imaging device at identifying the presence of bacteria in wounds at a plastic surgery outpatients clinic. J Wound Care. 2018;27(1):20-26. https://doi.org/10.12968/jowc.2018.27.1.20
Koo DY, Namgoong S, Han SK, et al. Diagnostic accuracy of a fluorescence imaging device in diabetic wounds: a pilot study using a tissue culture system. Wounds. 2023;35(7):E218-E223. https://doi.org/10.25270/wnds/23002
Olbrich A, Motekallemi A, Deschka H, et al. Prospective evaluation of the Moleculight i:X in the early detection of driveline infections. Interdiscip Cardiovasc Thorac Surg. 2025;40(4):ivae215. https://doi.org/10.1093/icvts/ivae215
Pijpe A, Ozdemir Y, Sinnige JC, et al. Detection of bacteria in burn wounds with a novel handheld autofluorescence wound imaging device: a pilot study. J Wound Care. 2019;28(8):548-554. https://doi.org/10.12968/jowc.2019.28.8.548
Ottolino-Perry K, Chamma E, Blackmore KM, et al. Improved detection of clinically relevant wound bacteria using autofluorescence image-guided sampling in diabetic foot ulcers. Int Wound J. 2017;14(5):833-841. https://doi.org/10.1111/iwj.12717
Serena TE, Snyder RJ, Bowler PG. Use of fluorescence imaging to optimize location of tissue sampling in hard-to-heal wounds. Front Cell Infect Microbiol. 2023;12:1070311. https://doi.org/10.3389/fcimb.2022.1070311
Mayer P, Smith AC, Hurlow J, Morrow BR, Bohn GA, Bowler PG. Assessing biofilm at the bedside: exploring reliable accessible biofilm detection methods. Diagnostics (Basel). 2024;14(19):2116. https://doi.org/10.3390/diagnostics14192116
Wu YF, Tung YC, Sheu SY, et al. Standardized quantitative imaging of extracellular polymeric substance in chronic wounds: prognostic comparison of wound blotting and bacterial fluorescence imaging. Biofilm. 2026;12:100392. https://doi.org/10.1016/j.bioflm.2026.100392
DasGupta T, Rashleigh L, Zhou K, et al. Use of a fluorescence imaging device to detect elevated bacterial loads, enhance antimicrobial stewardship, and increase communication across inpatient complex wound care teams. Wounds. 2022;34(8):201-208. https://doi.org/10.25270/wnds/21076
Serena TE, Gould L, Ousey K, Kirsner RS. Reliance on clinical signs and symptoms assessment leads to misuse of antimicrobials: post-hoc analysis of 350 chronic wounds. Adv Wound Care (New Rochelle). 2022;11(12):639-649. https://doi.org/10.1089/wound.2021.0146
Caputo WJ, Monterosa P, Beggs D. Antibiotic misuse in wound care: can bacterial localization through fluorescence imaging help? Diagnostics (Basel). 2022;12(12):3207. https://doi.org/10.3390/diagnostics12123207
Hill R, Rennie MY, Douglas J. Using bacterial fluorescence imaging and antimicrobial stewardship to guide wound management practices: a case series. Ostomy Wound Manage. 2018;64(8):18-28. https://doi.org/10.25270/owm.2018.8.1828
Cole W, Coe S. Use of a bacterial fluorescence imaging system to target wound debridement and accelerate healing: a pilot study. J Wound Care. 2020;29(Sup7):S44-S52. https://doi.org/10.12968/jowc.2020.29.Sup7.S44
Derwin R, Patton D, Strapp H, Moore Z. Integrating point-of-care bacterial fluorescence imaging-guided care with continued wound measurement for enhanced wound area reduction monitoring. Diagnostics (Basel). 2024;14(1):2. https://doi.org/10.3390/diagnostics14010002
Okeahialam NA, Thakar R, Sultan AH. The clinical progression and wound healing rate of dehisced perineal tears healing by secondary intention: a prospective observational study. Eur J Obstet Gynecol Reprod Biol. 2022;274:191-196. https://doi.org/10.1016/j.ejogrb.2022.05.035
Oropallo A, Rao AS, Kaplan S, et al. Absence of bacterial fluorescence is associated with early response to skin substitutes in diabetic and venous ulcers: a single-blinded prospective study. Int Wound J. 2026;23(5):e70951. https://doi.org/10.1111/iwj.70951
Hanson-Viana E, Rojas-Ortiz JA, Rendón-Medina MA, Luna-Zepeda BL. Bacterial fluorescence imaging as a predictor of skin graft integration in burn wounds. Burns. 2024;50(7):1799-1811. https://doi.org/10.1016/j.burns.2024.04.003
Blumenthal E, Jeffery SLA. The use of the MolecuLight i:X in managing burns: a pilot study. J Burn Care Res. 2018;39(1):154-161. https://doi.org/10.1097/BCR.0000000000000565
Farhan N, Jeffery S. Utility of MolecuLight i:X for managing bacterial burden in pediatric burns. J Burn Care Res. 2020;41(2):328-338. https://doi.org/10.1093/jbcr/irz167
Jeffery SLA, Hanson-Viana E. A scoping review of fluorescence imaging: a promising new technology for bacterial detection in burn wounds. J Burn Care Res. 2026;47(1):315-322. https://doi.org/10.1093/jbcr/iraf173
Badrie S, Moore Z, Patton D, O’Connor T, Derwin R. The clinical utility of autofluorescence imaging for bacterial detection in wounds: a systematic review. Int Wound J. 2025;22(6):e70678. https://doi.org/10.1111/iwj.70678
Berenguer-Pérez M, Manzanaro-García N, González-de la Torre H, et al. Systematic review and meta-analysis of diagnostic test accuracy in chronic wound’s microbiology. Int Wound J. 2024;21:e70063. https://doi.org/10.1111/iwj.70063
Oropallo AR, Andersen C, Abdo R, et al. Guidelines for point-of-care fluorescence imaging for detection of wound bacterial burden based on Delphi consensus. Diagnostics (Basel). 2021;11(7):1219. https://doi.org/10.3390/diagnostics11071219
Serena TE, Kapp D, Davenport T, et al. Fluorescence imaging in surgical wound management: a consensus-based approach. Int J Tissue Repair. 2025. https://doi.org/10.63676/pxws0177
International Wound Infection Institute. Wound Infection in Clinical Practice: Principles of Best Practice. International Consensus Update 2022. 3rd ed. https://woundsinternational.com/consensus-documents/wound-infection-in-clinical-practice-principles-of-best-practice (accessed 15 October 2026)
International Wound Infection Institute. Wound Infection in Clinical Practice: Principles of Best Practice. 4th ed. Wounds International; 2026. https://woundsinternational.com/consensus-documents/wound-infection-in-clinical-practice-principles-of-best-practice-fourth-edition/ (accessed 15 October 2026)
National Institute for Health and Care Excellence. MolecuLight i:X for wound imaging. Medtech innovation briefing MIB212. 2020. https://www.nice.org.uk/advice/mib212 (accessed 15 October 2026)
Edwards G, Carter A, Wallis C, Hayward G, Moore A. Identifying infection in chronic wounds in a community setting: a systematic review of diagnostic test accuracy studies. J Adv Nurs. 2024;80:73-83. https://doi.org/10.1111/jan.15822
American Medical Association. CPT Editorial Panel summary of panel actions, September 2025, Tab 57. https://www.ama-assn.org/system/files/sept-2025-summary-of-panel-actions.pdf (accessed 15 October 2026)
Centers for Medicare & Medicaid Services. Medicare and Medicaid programs; CY 2027 payment policies under the Physician Fee Schedule and other changes to Part B payment and coverage policies. Proposed rule (CMS-1848-P). Fed Regist. July 16, 2026. Document 2026-14327. https://www.federalregister.gov/d/2026-14327 (accessed 15 October 2026)
Published
Issue
Section
License
Copyright (c) 2026 International Journal of Tissue Repair

This work is licensed under a Creative Commons Attribution-NonCommercial-NoDerivatives 4.0 International License.